Chimeric antigen receptor-T cell (CAR-T cell) therapies have been a significant advance in the field of cancer immunotherapeutics in recent years, particularly for B-cell malignancies. Yet, this ...

G-CSF Limitations: These agents essentially overstimulate a bone marrow that is already damaged by chemotherapy. Furthermore, while they address neutrophils, they do not mitigate damage to platelets ...

Chronic illnesses don’t take Saturdays off, and neither does the team at the UAB O’Neal Comprehensive Cancer Center Infusion Clinic. Patients undergoing a wide range of infusion therapies, including ...

Recently, new immune-based treatments have shown impressive results when multiple myeloma returns, changing how doctors treat ...

The press release below was prepared by the American Association for Cancer Research. View the original here. Next-generation sequencing for minimal residual disease was highly sensitive and more ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Inducing temporary chimerism by transplanting donor Tregs and bone marrow after kidney transplantation was successful in a phase 1 and 2a trial. The hope is that it will reduce the risk for graft loss ...